BOARD OF DIRECTORS

    The Cancer Research & Treatment Fund (CR&T) is led by a Board of Directors that is supported by our Medical Advisory Board.  Together, they represent a broad cross-section of specialties and disciplines, working together to rapidly deploy funding to the frontlines of research and ensuring CR&T maintains its reputation as a leading voice in cancer research.

     
    Thomas M. Silver, President

    Principal, Silver Dollar Ventures, LLC.

     

    Richard T. Silver, MD, Vice President, Medical Director

    New York-Presbyterian/Weill Cornell Medicine

     

    David T. Boule, Treasurer

    Retired Partner, Ernst & Young

     

    Maria Brisbane, CFA

    Managing Director, Morgan Stanley

     

    Terry Hermanson

    President, Mr. Christmas, Inc.

     

    Michael C. Kempner

    Managing General Partner, KS Capital Partners, LP

     

    Kasia McCormick
     
    Amanda Johns Perez
     
    Jeffrey Puglisi, MD

    Glenville Medical Concierge Care

     
    Richard J. Rose

    Sr. Managing Director, Shufro, Rose & Co., LLC (Retired)

     
    Raj Shah

    Chief Investment Officer, The Hardy Group

     
    Todd J. Shaw

    Senior Vice President, Morgan Stanley

     

    Caleb Sexton

    Founder and CEO, Workforcely

     
    AJ Shiekman

    Strategy/Business Development Manager, Pure Storage

     

    Adam Silver

     

    Tim Silver

    Portfolio Manager, Empery Asset Management, LP

     

    Anne Templeton
     

     

    Counsel

    Nelson A. Boxer

    Partner, Petrillo Klein & Boxer LLP

     

    Staff

    Chad Feay, MA, CHES®

    Director of Administration and Development

    Mara Sanderson

    Administrative Specialist